See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2018_BIOSPECIFICS_TECHNOLOGIES_CORP.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000875622')"} |
Graph
Absolute values for 0000875622, BIOSPECIFICS TECHNOLOGIES CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 66,380,515 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 397,993 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 8,217,886 |
| 4 | LiabilitiesCurrent | 2,138,848 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,542,324 |
| 9 | ResearchAndDevelopmentExpense | 1,223,277 |
| 10 | remainder_Expenses | 7,037,527 |
| 11 | remainder_Revenues | 27,443,752 |
| 12 | remainder_NetIncome | 687,642 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 74,996,394 |
| 1 | Liabilities | 2,138,848 |
| 2 | Expenses | 16,803,128 |
| 3 | Revenues | 27,443,752 |
| 4 | StockholdersEquity | 72,857,546 |
| 5 | NetIncome | 11,328,266 |
| 6 | ComprehensiveNetIncome | 11,328,266 |
| 7 | BaseVar | 61,034,882 |
| 8 | EconomicCapitalRatio | 3.54 |
Edgar->Model Mapping
Feature Distribution
Change over Time
